Microbiota-directed biotherapeutics: considerations for quality and functional assessment

References

• Almeida A, Nayfach S, Boland M, Strozzi F, Beracochea M, Shi ZJ, Pollard KS, Sakharova E, Parks DH, Hugenholtz P, et al. A unified catalog of 204,938 reference genomes from the human gut microbiome. Nat Biotechnol. 2021;39(1):105–26. doi:10.1038/s41587-020-0603-3.
   PubMed Web of Science ®Google Scholar
• Qin J, Li, Ruiqiang. Raes, Jeroen. Arumugam, Manimozhiyan. Burgdorf, Kristoffe Solvsten. Manichanh, Chaysavanh. Nielsen, Trine. Pons, Nicolas. Levenez, Florence. Yamada, Takuji, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi:10.1038/nature08821.
   PubMed Web of Science ®Google Scholar
• Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32(8):834–841. doi:10.1038/nbt.2942.
   PubMed Web of Science ®Google Scholar
• Chibani CM, Mahnert A, Borrel G, Almeida A, Werner A, Brugère J-F, Gribaldo S, Finn RD, Schmitz RA, Moissl-Eichinger C. A catalogue of 1,167 genomes from the human gut archaeome. Nat Microbiol. 2022;7(1):48–61. doi:10.1038/s41564-021-01020-9.
   PubMed Web of Science ®Google Scholar
• Shkoporov AN, Clooney AG, Sutton TDS, Ryan FJ, Daly KM, Nolan JA, McDonnell SA, Khokhlova EV, Draper LA, Forde A, et al. The human Gut Virome is highly diverse, stable, and individual specific. Cell Host Microbe. 2019;26(4):527–541 e5. doi:10.1016/j.chom.2019.09.009.
   PubMed Web of Science ®Google Scholar
• Limon JJ, Skalski JH, Underhill DM. Commensal Fungi in Health and Dis Cell Host Microbe. 2017;22(2):156–165. 10.1016/j.chom.2017.07.002.
   PubMed Web of Science ®Google Scholar
• Nash AK, Auchtung, Thomas A. Wong, Matthew C. Smith, Daniel P. Gesell, Jonathan R. Ross, Matthew C. Stewart, Christopher J. Metcalf, Ginger A. Muzny, Donna M. Gibbs, Richard A, et al. The gut mycobiome of the human Microbiome project healthy cohort. Microbiome. 2017;5(1):153. doi:10.1186/s40168-017-0373-4.
   PubMedGoogle Scholar
• Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24(4):392–400. doi:10.1038/nm.4517.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li, Leyuan. Butcher, James. Stintzi, Alain. Figeys, Daniel. Advancing functional and translational microbiome research using meta-omics approaches. Microbiome. 2019;7(1):154. doi:10.1186/s40168-019-0767-6.
   PubMed Web of Science ®Google Scholar
• Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–270. doi:10.1038/nrg3182.
   PubMed Web of Science ®Google Scholar
• Dietert R. The human superorganism: how the microbiome is revolutionizing the pursuit of a healthy life. New York (NY): Penguin Publishing Group;2016. p.341.
   Google Scholar
• Zhao L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol. 2013;11(9):639–647. doi:10.1038/nrmicro3089.
   PubMed Web of Science ®Google Scholar
• Jia W, Li H, Zhao L, Nicholson JK. Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov. 2008;7(2):123–129. doi:10.1038/nrd2505.
   PubMed Web of Science ®Google Scholar
• Claesson MJ, Jeffery, Ian B. Conde, Susana. Power, Susan E. O’connor, Eibhlis M. Cusack, Siobhan. Harris, Hugh. Coakley, Mairead. Lakshminarayanan, Bhuvaneswari. O’sullivan, Orla. et al Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488(7410):178–184. doi:10.1038/nature11319.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice, Corinne F. Carmody, Rachel N. Gootenberg, David B. Button, Julie E. Wolfe, Benjamin E. Ling, Alisha V. Devlin, A Sloan. Varma, Yug. Fischbach, Michael A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi:10.1038/nature12820.
   PubMed Web of Science ®Google Scholar
• Maier L, Pruteanu, Mihaela. Kuhn, Michael. Zeller, Georg. Telzerow, Anja. Anderson, Exene Erin. Brochado, Ana Rita. Fernandez, Keith Conrad. Dose, Hitomi. Mori, Hirotada, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555(7698):623–628. doi:10.1038/nature25979.
   PubMed Web of Science ®Google Scholar
• Klunemann M, Andrejev, Sergej. Blasche, Sonja. Mateus, Andre. Phapale, Prasad. Devendran, Saravanan. Vappiani, Johanna. Simon, Bernd. Scott, Timothy A. Kafkia, Eleni, et al. Bioaccumulation of therapeutic drugs by human gut bacteria. Nature. 2021;597(7877):533–538. doi:10.1038/s41586-021-03891-8.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Zimmermann-Kogadeeva, Maria. Wegmann, Rebekka. Goodman, Andrew L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462–467. doi:10.1038/s41586-019-1291-3.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Patil KR, Typas A, Maier L. Towards a mechanistic understanding of reciprocal drug–microbiome interactions. Mol Syst Biol. 2021;17(3):e10116. doi:10.15252/msb.202010116.
   PubMed Web of Science ®Google Scholar
• Zhu W, Winter, Maria G. Byndloss, Mariana X. Spiga, Luisella. Duerkop, Breck A. Hughes, Elizabeth R. Buttner, Lisa. de Lima Romao, Everton. Behrendt, Cassie L. Lopez, Christopher A., et al. Precision editing of the gut microbiota ameliorates colitis. Nature. 2018;553(7687):208–211. doi:10.1038/nature25172.
   PubMed Web of Science ®Google Scholar
• McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987–994. doi:10.1093/cid/ciy149.
   PubMed Web of Science ®Google Scholar
• Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, Wilcox MH. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and society for healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021;73(5):e1029–1044. doi:10.1093/cid/ciab549.
   PubMed Web of Science ®Google Scholar
• Cammarota G, Ianiro, Gianluca. Tilg, Herbert. Rajilic-Stojanovic, Mirjana. Kump, Patrizia. Satokari, Reetta. Sokol, Harry. Arkkila, Perttu. Pintus, Cristina. Hart, Ailsa, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66(4):569–580. doi:10.1136/gutjnl-2016-313017.
   PubMed Web of Science ®Google Scholar
• Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin J-M, Morrison RM, Deblasio RN, Menna C, Ding Q, Pagliano O, et al. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients. Science. 2021;371(6529):595–602. doi:10.1126/science.abf3363.
   PubMed Web of Science ®Google Scholar
• Baruch EN, Youngster, Ilan. Ben-Betzalel, Guy. Ortenberg, Rona. Lahat, Adi. Katz, Lior. Adler, Katerina. Dick-Necula, Daniela. Raskin, Stephen. Bloch, Naamah, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Sci. 2021;371(6529):602–609. doi:10.1126/science.abb5920.
   PubMed Web of Science ®Google Scholar
• Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, Aroniadis O, Barto A, Borody T, Giovanelli A, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–1071. doi:10.1038/ajg.2014.133.
   PubMed Web of Science ®Google Scholar
• Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, Bakow B, Curran P, McKenney J, Tisch A, et al. Effect of Fecal Microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med. 2016;165(9):609–616. doi:10.7326/M16-0271.
   PubMed Web of Science ®Google Scholar
• Costello SP, Hughes, Patrick A. Waters, Oliver. Bryant, Robert V. Vincent, Andrew D. Blatchford, Paul. Katsikeros, Rosa. Makanyanga, Jesica. Campaniello, Melissa A. Mavrangelos, Chris, et al. Effect of Fecal Microbiota transplantation on 8-week remission in patients with Ulcerative Colitis: a randomized clinical trial. JAMA. 2019;321(2):156–164. doi:10.1001/jama.2018.20046.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Gavis, Edith A. Fagan, Andrew. Wade, James B. Thacker, Leroy R. Fuchs, Michael. Patel, Samarth. Davis, Brian. Meador, Jill. Puri, Puneet, et al. A randomized clinical trial of fecal microbiota transplant for Alcohol use disorder. Hepatology. 2021;73(5):1688–1700. doi:10.1002/hep.31496.
   PubMed Web of Science ®Google Scholar
• Mocanu V, Zhang Z, Deehan EC, Kao DH, Hotte N, Karmali S, Birch DW, Samarasinghe KK, Walter J, Madsen KL. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nat Med. 2021;27(7):1272–1279. doi:10.1038/s41591-021-01399-2.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk, Jan Gunnar. Gilja, Odd Helge. Kristoffersen, Anja Brathen. Hausken, Trygve. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69(5):859–867. doi:10.1136/gutjnl-2019-319630.
   PubMed Web of Science ®Google Scholar
• Park SH, Lee JH, Shin J, Kim J-S, Cha B, Lee S, Kwon KS, Shin YW, Choi SH. Cognitive function improvement after fecal microbiota transplantation in Alzheimer’s dementia patient: a case report. Curr Med Res Opin. 2021;37(10):1739–1744. doi:10.1080/03007995.2021.1957807.
   PubMed Web of Science ®Google Scholar
• Sun J, Xu J, Ling Y, Wang F, Gong T, Yang C, Ye S, Ye K, Wei D, Song Z, et al. Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice. Transl Psychiatry. 2019;9(1):189. doi:10.1038/s41398-019-0525-3.
   PubMed Web of Science ®Google Scholar
• Kang DW, Adams JB, Coleman DM, Pollard EL, Maldonado J, McDonough-Means S, Caporaso JG, Krajmalnik-Brown R. Long-term benefit of Microbiota transfer therapy on autism symptoms and gut microbiota. Sci Rep. 2019;9(1):5821. doi:10.1038/s41598-019-42183-0.
   PubMedGoogle Scholar
• Li N, Chen H, Cheng Y, Xu F, Ruan G, Ying S, Tang W, Chen L, Chen M, Lv L, et al. Corrigendum: fecal Microbiota transplantation relieves gastrointestinal and Autism symptoms by improving the gut Microbiota in an open-label study. Front Cell Infect Microbiol. 2021;11:801376. doi:10.3389/fcimb.2021.801376.
   PubMed Web of Science ®Google Scholar
• Parker A, Romano, Stefano. Ansorge, Rebecca. Aboelnour, Asmaa. Le Gall, Gwenaelle. Savva, George M. Pontifex, Matthew G. Telatin, Andrea. Baker, David. Jones, Emily, et al. Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome. 2022;10(1):68. doi:10.1186/s40168-022-01243-w.
   PubMed Web of Science ®Google Scholar
• Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, Luu LDW, Borody TJ, Leong RW. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7(2):141–151. doi:10.1016/S2468-1253(21)00400-3.
   PubMed Web of Science ®Google Scholar
• Jiang ZD, Jenq RR, Ajami NJ, Petrosino JF, Alexander AA, Ke S, Iqbal T, DuPont AW, Muldrew K, Shi Y, et al. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: a randomized clinical trial. PLoS One. 2018;13(11):e0205064. doi:10.1371/journal.pone.0205064.
   PubMed Web of Science ®Google Scholar
• Stallmach A, Steube A, Grunert P, Hartmann M, Biehl LM, Vehreschild MJGT. Deutsches Ärzteblatt Int. 2020;117(3):31–38. 10.3238/arztebl.2020.0031.
   PubMed Web of Science ®Google Scholar
• Ott SJ, Waetzig GH, Rehman A, Moltzau-Anderson J, Bharti R, Grasis JA, Cassidy L, Tholey A, Fickenscher H, Seegert D, et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile Infection. Gastroenterology. 2017;152(4):799–811 e7. doi:10.1053/j.gastro.2016.11.010.
   PubMed Web of Science ®Google Scholar
• Brunse A, Deng L, Pan X, Hui Y, Castro-Mejía JL, Kot W, Nguyen DN, Secher JBM, Nielsen DS, Thymann T. Fecal filtrate transplantation protects against necrotizing enterocolitis. Isme J. 2022;16(3):686–694. doi:10.1038/s41396-021-01107-5.
   PubMed Web of Science ®Google Scholar
• McGovern BH, Ford CB, Henn MR, Pardi DS, Khanna S, Hohmann EL, O’brien EJ, Desjardins CA, Bernardo P, Wortman JR, et al. SER-109, an investigational microbiome drug to reduce recurrence after Clostridioides difficile infection: lessons learned from a phase 2 trial. Clin Infect Dis. 2021;72(12):2132–2140. doi:10.1093/cid/ciaa387.
   PubMed Web of Science ®Google Scholar
• Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, Sims M, Kraft CS, Cohen SH, Berenson CS, et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med. 2022;386(3):220–229. doi:10.1056/NEJMoa2106516.
   PubMed Web of Science ®Google Scholar
• Petrof EO, Gloor, Gregory B. Vanner, Stephen J. Weese, Scott J. Carter, David. Daigneault, Michelle C. Brown, Eric M. Schroeter, Kathleen. Allen-Vercoe, Emma. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePoopulating’ the gut. Microbiome. 2013;1(1):3. doi:10.1186/2049-2618-1-3.
   PubMed Web of Science ®Google Scholar
• Kao D, Wong K, Franz R, Cochrane K, Sherriff K, Chui L, Lloyd C, Roach B, Bai AD, Petrof EO, et al. The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial. Lancet Gastroenterol Hepatol. 2021;6(4):282–291. doi:10.1016/S2468-1253(21)00007-8.
   PubMed Web of Science ®Google Scholar
• Cheng AG, Ho P-Y, Aranda-Díaz A, Jain S, Yu FB, Meng X, Wang M, Iakiviak M, Nagashima K, Zhao A, et al. Design, construction, and in vivo augmentation of a complex gut microbiome. Cell. 2022;185:3617–3636.e19. doi:10.1016/j.cell.2022.08.003.
   PubMed Web of Science ®Google Scholar
• Buffie CG, Bucci, Vanni. Stein, Richard R. McKenney, Peter T. Ling, Lilan. Gobourne, Asia. No, Daniel. Liu, Hui. Kinnebrew, Melissa. Viale, Agnes, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517(7533):205–208. doi:10.1038/nature13828.
   PubMed Web of Science ®Google Scholar
• Mabwi HA, Kim E, Song D-G, Yoon HS, Pan C-H, Komba EVG, Ko G, Cha KH. 2021. Synthetic gut microbiome: advances and challenges. Comput Struct Biotechnol J. 19:363–371. doi:10.1016/j.csbj.2020.12.029.
   PubMed Web of Science ®Google Scholar
• O’toole PW, Marchesi JR, Hill C. 2017. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol. 2:17057. doi:10.1038/nmicrobiol.2017.57.
   PubMed Web of Science ®Google Scholar
• Langella P, Guarner F, Martin R, Editorial: next-Generation probiotics: from commensal Bacteria to novel drugs and food supplements. Front Microbiol. 2019;10:1973.
   PubMed Web of Science ®Google Scholar
• Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(5):1469–1476. doi:10.1099/ijs.0.02873-0.
   PubMed Web of Science ®Google Scholar
• Cani PD, de Vos WM. 2017. Next-Generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol. 8:1765. doi:10.3389/fmicb.2017.01765.
   PubMed Web of Science ®Google Scholar
• Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107–113. doi:10.1038/nm.4236.
   PubMed Web of Science ®Google Scholar
• Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, Zhao J, Zhang H, Chen W. Blautia —a new functional genus with potential probiotic properties? Gut Microbes. 2021;13(1):1–21. doi:10.1080/19490976.2021.1875796.
   Web of Science ®Google Scholar
• Sen P, Sherwin E, Sandhu K, Bastiaanssen TFS, Moloney GM, Golubeva A, Fitzgerald P, Paula Ventura Da Silva A, Chruścicka-Smaga B, Olavarría-Ramírez L, et al. The live biotherapeutic Blautia stercoris MRx0006 attenuates social deficits, repetitive behaviour, and anxiety-like behaviour in a mouse model relevant to autism. Brain Behav Immun. 2022;106:115–126. doi:10.1016/j.bbi.2022.08.007.
   PubMed Web of Science ®Google Scholar
• Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016;8(339):339ra71. doi:10.1126/scitranslmed.aaf2311.
   PubMed Web of Science ®Google Scholar
• Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S, et al. Post-antibiotic gut Mucosal microbiome reconstitution is impaired by probiotics and improved by Autologous FMT. Cell. 2018;174(6):1406–1423 e16. doi:10.1016/j.cell.2018.08.047.
   PubMed Web of Science ®Google Scholar
• Charbonneau MR, Isabella VM, Li N, Kurtz CB. Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nat Commun. 2020;11(1):1738. doi:10.1038/s41467-020-15508-1.
   PubMed Web of Science ®Google Scholar
• Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA, et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol. 2018;36(9):857–864. doi:10.1038/nbt.4222.
   PubMed Web of Science ®Google Scholar
• Puurunen MK, Vockley J, Searle SL, Sacharow SJ, Phillips JA, Denney WS, Goodlett BD, Wagner DA, Blankstein L, Castillo MJ, et al. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Nat Metab. 2021;3(8):1125–1132. doi:10.1038/s42255-021-00430-7.
   PubMedGoogle Scholar
• Leventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, Christmas R, Gao J-R, James MJ, Abin-Fuentes A, et al. Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat Commun. 2020;11(1):2739. doi:10.1038/s41467-020-16602-0.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang, X., Walker, K., Mayne, J., Li, L., Ning, Z., Stintzi, A., Figeys, D. Evaluating live microbiota biobanking using an ex vivo microbiome assay and metaproteomics. Gut Microbes. 2022;14(1):2035658. doi:10.1080/19490976.2022.2035658.
   PubMed Web of Science ®Google Scholar
• Laxminarayan R. The overlooked pandemic of antimicrobial resistance. Lancet. 2022;399(10325):606–607. doi:10.1016/S0140-6736(22)00087-3.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0.
   PubMed Web of Science ®Google Scholar
• Cubillos-Ruiz A, Alcantar MA, Donghia NM, Cárdenas P, Avila-Pacheco J, Collins JJ. An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis. Nat Biomed Eng. 2022;6(7):910–921. doi:10.1038/s41551-022-00871-9.
   PubMed Web of Science ®Google Scholar
• Koh E, Hwang IY, Lee HL, De Sotto R, Lee JWJ, Lee YS, March JC, Chang MW. Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism. Nat Commun. 2022;13(1):3834. doi:10.1038/s41467-022-31334-z.
   PubMed Web of Science ®Google Scholar
• Hatfull GF, Dedrick RM, Schooley RT. 2022. Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med. 73:197–211. doi:10.1146/annurev-med-080219-122208.
   PubMed Web of Science ®Google Scholar
• Khan Mirzaei M, Deng L. New technologies for developing phage-based tools to manipulate the human microbiome. Trends Microbiol. 2022;30(2):131–142. doi:10.1016/j.tim.2021.04.007.
   PubMed Web of Science ®Google Scholar
• Duan Y, Llorente, Cristina. Lang, Sonja. Brandl, Katharina. Chu, Huikuan. Jiang, Lu. White, Richard C. Clarke, Thomas H. Nguyen, Kevin. Torralba, Manolito, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575(7783):505–511. doi:10.1038/s41586-019-1742-x.
   PubMed Web of Science ®Google Scholar
• Federici S, Kredo-Russo S, Valdés-Mas R, Kviatcovsky D, Weinstock E, Matiuhin Y, Silberberg Y, Atarashi K, Furuichi M, Oka A, et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell. 2022;185(16):2879–2898 e24. doi:10.1016/j.cell.2022.07.003.
   PubMed Web of Science ®Google Scholar
• Wegh CAM. Postbiotics anD their potential applications in early life nutrition and beyond. Int J Mol Sci. 2019;20(19):4673. doi:10.3390/ijms20194673.
   PubMed Web of Science ®Google Scholar
• Zolkiewicz J, Marzec A, Ruszczyński M, Feleszko W. Postbiotics—a step beyond pre- and Probiotics. Nutrients. 2020;12(8):2189. doi:10.3390/nu12082189.
   PubMed Web of Science ®Google Scholar
• Sarikaya H, Aslim B, Yuksekdag Z. Assessment of anti-biofilm activity and bifidogenic growth stimulator (BGS) effect of lyophilized exopolysaccharides (l-EPSs) from Lactobacilli strains. Intern J Food Pro. 2017;20(2):362–371. doi:10.1080/10942912.2016.1160923.
   Web of Science ®Google Scholar
• Song AX, Mao Y-H, Siu K-C, Wu J-Y. 2018. Bifidogenic effects of Cordyceps sinensis fungal exopolysaccharide and konjac glucomannan after ultrasound and acid degradation. Int J Biol Macromol. 111:587–594. doi:10.1016/j.ijbiomac.2018.01.052.
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389–395. doi:10.1038/415389a.
   PubMed Web of Science ®Google Scholar
• Ma Y, Guo Z, Xia B, Zhang Y, Liu X, Yu Y, Tang N, Tong X, Wang M, Ye X, et al. Identification of antimicrobial peptides from the human gut microbiome using deep learning. Nat Biotechnol. 2022;40(6):921–931. doi:10.1038/s41587-022-01226-0.
   PubMed Web of Science ®Google Scholar
• Yeung AT, Gellatly SL, Hancock RE. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci. 2011;68(13):2161–2176. doi:10.1007/s00018-011-0710-x.
   PubMed Web of Science ®Google Scholar
• Zhang X, Deeke SA, Ning Z, Starr AE, Butcher J, Li J, Mayne J, Cheng K, Liao B, Li L, et al. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun. 2018;9(1):2873. doi:10.1038/s41467-018-05357-4.
   PubMed Web of Science ®Google Scholar
• Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J, Gonzalez A, Kosciolek T, McCall L-I, McDonald D, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16(7):410–422. doi:10.1038/s41579-018-0029-9.
   PubMed Web of Science ®Google Scholar
• Morgan XC, Huttenhower C. Meta’omic analytic techniques for studying the intestinal microbiome. Gastroenterology. 2014;146(6):1437–1448 e1. doi:10.1053/j.gastro.2014.01.049.
   PubMed Web of Science ®Google Scholar
• Valles-Colomer M, Darzi Y, Vieira-Silva S, Falony G, Raes J, Joossens M. Meta-omics in Inflammatory Bowel Disease Research: applications, Challenges, and Guidelines. J Crohns Colitis. 2016;10(6):735–746. doi:10.1093/ecco-jcc/jjw024.
   PubMed Web of Science ®Google Scholar
• Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857. doi:10.1038/s41587-019-0209-9.
   PubMed Web of Science ®Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998. doi:10.1038/nmeth.2604.
   PubMed Web of Science ®Google Scholar
• Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–583. doi:10.1038/nmeth.3869.
   PubMed Web of Science ®Google Scholar
• Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814–821. doi:10.1038/nbt.2676.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Mahurkar, Anup. Rahnavard, Gholamali. Crabtree, Jonathan. Orvis, Joshua. Hall, A Brantley. Brady, Arthur. Creasy, Heather H. McCracken, Carrie. Giglio, Michelle G., et al .Strains, functions and dynamics in the expanded human microbiome project. Nature. 2017;550(7674):61–66. doi:10.1038/nature23889.
   PubMed Web of Science ®Google Scholar
• Schirmer M, Franzosa EA, Lloyd-Price J, McIver LJ, Schwager R, Poon TW, Ananthakrishnan AN, Andrews E, Barron G, Lake K, et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol. 2018;3(3):337–346. doi:10.1038/s41564-017-0089-z.
   PubMed Web of Science ®Google Scholar
• Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, Tett A, Huttenhower C, Segata N. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015;12(10):902–903. doi:10.1038/nmeth.3589.
   PubMed Web of Science ®Google Scholar
• Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20(1):257. doi:10.1186/s13059-019-1891-0.
   PubMed Web of Science ®Google Scholar
• Kultima JR, Coelho, Luis Pedro. Forslund, Kristoffer. Huerta-Cepas, Jaime. Li, Simone S. Driessen, Marja. Voigt, Anita Yvonne. Zeller, Georg. Sunagawa, Shinichi. Bork, Peer, et al. MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics. 2016;32(16):2520–2523. doi:10.1093/bioinformatics/btw183.
   PubMed Web of Science ®Google Scholar
• Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, Lipson KS, Knight R, Caporaso JG, Segata N, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–968. doi:10.1038/s41592-018-0176-y.
   PubMed Web of Science ®Google Scholar
• Peters DL, Cheng, K, Ning, Z., Zhang, X., Li, L., Liao, B., Mayne, J., Figeys, D., Figeys, D. Metaproteomic and metabolomic approaches for characterizing the gut Microbiome. Proteomics. 2019;19(16):e1800363. doi:10.1002/pmic.201800363.
   PubMed Web of Science ®Google Scholar
• Hughes CS, Moggridge S, Müller T, Sorensen PH, Morin GB, Krijgsveld J. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat Protoc. 2019;14(1):68–85. doi:10.1038/s41596-018-0082-x.
   PubMed Web of Science ®Google Scholar
• Li J, Cai Z, Bomgarden RD, Pike I, Kuhn K, Rogers JC, Roberts TM, Gygi SP, Paulo JA. Tmtpro-18plex: the Expanded and Complete Set of TMTpro Reagents for Sample Multiplexing. J Proteome Res. 2021;20(5):2964–2972. doi:10.1021/acs.jproteome.1c00168.
   PubMed Web of Science ®Google Scholar
• Creskey M, Li L, Ning Z, Fekete EE, Mayne J, Walker K, Ampaw A, Ben R, Zhang X, Figeys D. An economic and robust TMT labeling approach for high throughput proteomic and metaproteomic analysis. Proteomics. 2022;e2200116. doi:10.1002/pmic.202200116.
   PubMed Web of Science ®Google Scholar
• Zhang X, Figeys D. Perspective and guidelines for metaproteomics in microbiome studies. J Proteome Res. 2019;18(6):2370–2380. doi:10.1021/acs.jproteome.9b00054.
   PubMed Web of Science ®Google Scholar
• Kleiner M. Metaproteomics: Much more than measuring gene expression in microbial communities. mSystems. 2019;4(3). doi:10.1128/mSystems.00115-19.
   PubMed Web of Science ®Google Scholar
• Li L, Figeys D. Proteomics and metaproteomics add functional, Taxonomic and biomass dimensions to modeling the Ecosystem at the Mucosal-luminal interface. Mol Cell Proteomics. 2020;19(9):1409–1417. doi:10.1074/mcp.R120.002051.
   PubMed Web of Science ®Google Scholar
• Starr AE, Deeke SA, Li L, Zhang X, Daoud R, Ryan J, Ning Z, Cheng K, Nguyen LVH, Abou-Samra E, et al. Proteomic and Metaproteomic approaches to understand host–Microbe interactions. Anal Chem. 2018;90(1):86–109. doi:10.1021/acs.analchem.7b04340.
   PubMed Web of Science ®Google Scholar
• Cheng K, Cheng, K., Ning, Z., Zhang, X., Li, L., Liao, B., Mayne, J., Stintzi, A., Figeys, D. MetaLab: an automated pipeline for metaproteomic data analysis. Microbiome. 2017;5(1):157. doi:10.1186/s40168-017-0375-2.
   PubMed Web of Science ®Google Scholar
• Schiebenhoefer H, Schallert K, Renard BY, Trappe K, Schmid E, Benndorf D, Riedel K, Muth T, Fuchs S. A complete and flexible workflow for metaproteomics data analysis based on MetaProteomeAnalyzer and Prophane. Nat Protoc. 2020;15(10):3212–3239. doi:10.1038/s41596-020-0368-7.
   PubMed Web of Science ®Google Scholar
• Tautenhahn R, Patti GJ, Rinehart D, Siuzdak G. XCMS Online: a web-based platform to process untargeted metabolomic data. Anal Chem. 2012;84(11):5035–5039. doi:10.1021/ac300698c.
   PubMed Web of Science ®Google Scholar
• Pang Z, Zhou G, Ewald J, Chang L, Hacariz O, Basu N, Xia J. Using MetaboAnalyst 5.0 for LC–HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat Protoc. 2022;17(8):1735–1761. doi:10.1038/s41596-022-00710-w.
   PubMed Web of Science ®Google Scholar
• Heintz-Buschart A, May P, Laczny CC, Lebrun LA, Bellora C, Krishna A, Wampach L, Schneider JG, Hogan A, de Beaufort C, et al. Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat Microbiol. 2016;2:16180. doi:10.1038/nmicrobiol.2016.180.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Arze, Cesar. Ananthakrishnan, Ashwin N. Schirmer, Melanie. Avila-Pacheco, Julian. Poon, Tiffany W. Andrews, Elizabeth. Ajami, Nadim J. Bonham, Kevin S. Brislawn, Colin J, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-9.
   PubMed Web of Science ®Google Scholar
• Vandeputte D, Kathagen, Gunter. D’hoe, Kevin. Vieira-Silva, Sara. Valles-Colomer, Mireia. Sabino, Joao. Wang, Jun. Tito, Raul Y. De Commer, Lindsey. Darzi, Youssef, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017;551(7681):507–511. doi:10.1038/nature24460.
   PubMed Web of Science ®Google Scholar
• Kleiner M, Thorson E, Sharp CE, Dong X, Liu D, Li C, Strous M. Assessing species biomass contributions in microbial communities via metaproteomics. Nat Commun. 2017;8(1):1558. doi:10.1038/s41467-017-01544-x.
   PubMed Web of Science ®Google Scholar
• Li L, Ning, Zhibin. Zhang, Xu. Mayne, Janice. Cheng, Kai. Stintzi, Alain. Figeys, Daniel. RapidAIM: a culture- and metaproteomics-based Rapid Assay of Individual Microbiome responses to drugs. Microbiome. 2020;8(1):33. doi:10.1186/s40168-020-00806-z.
   PubMed Web of Science ®Google Scholar
• Thomson CA, Morgan SC, Ohland C, McCoy KD. 2022. From germ-free to wild: modulating microbiome complexity to understand mucosal immunology. Mucosal Immunol. 15:1085–1094. doi:10.1038/s41385-022-00562-3.
   PubMed Web of Science ®Google Scholar
• Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 2005;21(1):1–26. doi:10.1007/s10565-005-0085-6.
   PubMed Web of Science ®Google Scholar
• Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2001;46(1–3):27–43. doi:10.1016/S0169-409X(00)00128-9.
   PubMed Web of Science ®Google Scholar
• Nagashima K, Zhao, Aishan. Atabakhsh, Katayoon. Weakley, Allison. Jain, Sunit. Meng, Xiandong. Cheng, Alice. Wang, Min. Higginbottom, Steven, and Dimas, Alex, et al. Mapping the T cell repertoire to a complex gut bacterial community. bioRxiv. 2022;2022.05.04.490632. doi:10.1101/2022.05.04.490632.
   Google Scholar
• Schape SS, Krause JL, Masanetz RK, Riesbeck S, Starke R, Rolle-Kampczyk U, Eberlein C, Heipieper H-J, Herberth G, von Bergen M, et al. Environmentally relevant concentration of bisphenol s shows Slight Effects on SIHUMIx. Microorganisms. 2020;8(9):1436. doi:10.3390/microorganisms8091436.
   PubMed Web of Science ®Google Scholar
• Krause JL, Schaepe SS, Fritz-Wallace K, Engelmann B, Rolle-Kampczyk U, Kleinsteuber S, Schattenberg F, Liu Z, Mueller S, Jehmlich N, et al. Following the community development of SIHUMIx – a new intestinal in vitro model for bioreactor use. Gut Microbes. 2020;11(4):1116–1129. doi:10.1080/19490976.2019.1702431.
   PubMed Web of Science ®Google Scholar
• Molly K, Vande Woestyne M, Verstraete W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biotechnol. 1993;39(2):254–258. doi:10.1007/BF00228615.
   PubMed Web of Science ®Google Scholar
• Minekus M. The TNO Gastro-Intestinal Model (TIM). 2015. p. 37–46.
   Google Scholar
• Venema K. The TNO in vitro Model of the Colon (TIM-2). 2015. p. 293–304.
   Google Scholar
• Westerhout J, Steeg EVD, Grossouw D, Zeijdner EE, Krul CAM, Verwei M, Wortelboer HM. 2014. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. Eur J Pharm Sci. 63:167–177. doi:10.1016/j.ejps.2014.07.003.
   PubMed Web of Science ®Google Scholar
• Lagier JC, Khelaifia S, Alou MT, Ndongo S, Dione N, Hugon P, Caputo A, Cadoret F, Traore SI, Seck EH, et al. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol. 2016;1:16203. doi:10.1038/nmicrobiol.2016.203.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang X, Ning Z, Mayne J, Moore JI, Butcher J, Chiang C-K, Mack D, Stintzi A, Figeys D. Evaluating in vitro culture medium of gut microbiome with Orthogonal experimental design and a Metaproteomics approach. J Proteome Res. 2018;17(1):154–163. doi:10.1021/acs.jproteome.7b00461.
   PubMed Web of Science ®Google Scholar
• Li L, Abou-Samra E, Ning Z, Zhang X, Mayne J, Wang J, Cheng K, Walker K, Stintzi A, Figeys D. An in vitro model maintaining taxon-specific functional activities of the gut microbiome. Nat Commun. 2019;10(1):4146. doi:10.1038/s41467-019-12087-8.
   PubMed Web of Science ®Google Scholar
• Li L, Chang, Lu. Zhang, Xu. Ning, Zhibin. Mayne, Janice. Ye, Yang. Stintzi, Alain. Liu, Jia. Figeys, Daniel, et al. Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes. Gut Microbes. 2020;11(5):1348–1361. doi:10.1080/19490976.2020.1755413.
   PubMed Web of Science ®Google Scholar
• Li L, Ryan J, Ning Z, Zhang X, Mayne J, Lavallée-Adam M, Stintzi A, Figeys D. 2020. A functional ecological network based on metaproteomics responses of individual gut microbiomes to resistant starches. Comput Struct Biotechnol J. 18:3833–3842. doi:10.1016/j.csbj.2020.10.042.
   PubMed Web of Science ®Google Scholar
• Sun Z, Wang W, Li L, Zhang X, Ning Z, Mayne J, Walker K, Stintzi A, Figeys D. Comprehensive assessment of functional effects of commonly used sugar substitute sweeteners on ex vivo Human Gut Microbiome. Microbiol Spectr. 2022;10(4):e0041222. doi:10.1128/spectrum.00412-22.
   PubMed Web of Science ®Google Scholar
• Javdan B, Lopez JG, Chankhamjon P, Lee YCJ, Hull R, Wu Q, Wang X, Chatterjee S, Donia MS. Personalized mapping of drug metabolism by the human gut Microbiome. Cell. 2020;181(7):1661–1679 e22. doi:10.1016/j.cell.2020.05.001.
   PubMed Web of Science ®Google Scholar
• Peterson MD, Mooseker MS. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci. 1992;102(Pt3):581–600. doi:10.1242/jcs.102.3.581.
   PubMedGoogle Scholar
• Antunes F, Andrade F, Araújo F, Ferreira D, Sarmento B. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm. 2013;83(3):427–435. doi:10.1016/j.ejpb.2012.10.003.
   PubMed Web of Science ®Google Scholar
• Darling NJ, Mobbs CL, González-Hau AL, Freer M, Przyborski S. 2020. Bioengineering novel in vitro co-culture models that represent the human intestinal mucosa with improved Caco-2 structure and barrier function. Front Bioeng Biotech. 8:992. doi:10.3389/fbioe.2020.00992.
   PubMed Web of Science ®Google Scholar
• Hu M, Li Y, Huang J, Wang X, Han J. Electrospun Scaffold for Biomimic culture of Caco-2 Cell monolayer as an in vitro intestinal model. ACS Appl Bio Mater. 2021;4(2):1340–1349. doi:10.1021/acsabm.0c01230.
   PubMedGoogle Scholar
• Taebnia N, Zhang R, Kromann EB, Dolatshahi-Pirouz A, Andresen TL, Larsen NB. Dual-material 3d-printed intestinal model devices With integrated Villi-like Scaffolds. ACS Appl Mater Interfaces. 2021;13(49):58434–58446. doi:10.1021/acsami.1c22185.
   PubMed Web of Science ®Google Scholar
• Shah P, Fritz JV, Glaab E, Desai MS, Greenhalgh K, Frachet A, Niegowska M, Estes M, Jäger C, Seguin-Devaux C, et al. A microfluidics-based in vitro model of the gastrointestinal human–microbe interface. Nat Commun. 2016;7:11535. doi:10.1038/ncomms11535.
   PubMed Web of Science ®Google Scholar
• Song WS, Shin SG, Jo S-H, Lee J-S, Jeon H-J, Kwon J-E, Park J-H, Cho S, Jeong JH, Kim B-G, et al. Development of an in vitro coculture device for the investigation of host–microbe interactions via integrative multiomics approaches. Biotechnol Bioeng. 2021;118(4):1612–1623. doi:10.1002/bit.27676.
   PubMed Web of Science ®Google Scholar
• Maurer M, Gresnigt, Mark S. Last, Antonia. Wollny, Tony. Berlinghof, Florian. Pospich, Rebecca. Cseresnyes, Zoltan. Medyukhina, Anna. Graf, Katja. Groeger, Marko, et al. A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies. Biomaterials. 2019;220:119396. doi:10.1016/j.biomaterials.2019.119396.
   PubMed Web of Science ®Google Scholar
• Barker N, Van Es, Johan H. Kuipers, Jeroen. Kujala, Pekka. Van Den Born, Maaike. Cozijnsen, Miranda. Haegebarth, Andrea. Korving, Jeroen. Begthel, Harry. Peters, Peter J. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003–1007. doi:10.1038/nature06196.
   PubMed Web of Science ®Google Scholar
• Sato T, Vries, Robert G. Snippert, Hugo J. Van De Wetering, Marc. Barker, Nick. Stange, Daniel E. Van Es, Johan H. Abo, Arie. Kujala, Pekka. Peters, Peter J, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244):262–265. doi:10.1038/nature07935.
   PubMed Web of Science ®Google Scholar
• Mead BE, Hattori K, Levy L, Imada S, Goto N, Vukovic M, Sze D, Kummerlowe C, Matute JD, Duan J, et al. Screening for modulators of the cellular composition of gut epithelia via organoid models of intestinal stem cell differentiation. Nat Biomed Eng. 2022;6(4):476–494. doi:10.1038/s41551-022-00863-9.
   PubMed Web of Science ®Google Scholar
• Mithal A, Capilla A, Heinze D, Berical A, Villacorta-Martin C, Vedaie M, Jacob A, Abo K, Szymaniak A, Peasley M, et al. Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells. Nat Commun. 2020;11(1):215. doi:10.1038/s41467-019-13916-6.
   PubMed Web of Science ®Google Scholar
• Sasaki N, Miyamoto K, Maslowski KM, Ohno H, Kanai T, Sato T. Development of a scalable coculture system for gut Anaerobes and Human Colon Epithelium. Gastroenterology. 2020;159(1):388–390 e5. doi:10.1053/j.gastro.2020.03.021.
   PubMed Web of Science ®Google Scholar
• Tan HY, Trier S, Rahbek UL, Dufva M, Kutter JP, Andresen TL. A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies. PLoS One. 2018;13(5):e0197101. doi:10.1371/journal.pone.0197101.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Konishi K, Yamazaki Y, Taki Y, Sakane T, Sezaki H, Furuyama Y. New and better protocols for a short-term Caco-2 cell culture system. J Pharm Sci. 2002;91(3):669–679. doi:10.1002/jps.10050.
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang Y-J, Yoon JY, Kemmitt J, Wright C, Schneider K, Sphabmixay P, Hernandez-Gordillo V, Holcomb SJ, Bhushan B, et al. Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive Faecalibacterium prausnitzii in continuous culture. Med (N Y). 2021;2(1):74–98 e9. doi:10.1016/j.medj.2020.07.001.
   PubMedGoogle Scholar
• Puschhof J, Pleguezuelos-Manzano C, Martinez-Silgado A, Akkerman N, Saftien A, Boot C, de Waal A, Beumer J, Dutta D, Heo I, et al. Intestinal organoid cocultures with microbes. Nat Protoc. 2021;16(10):4633–4649. doi:10.1038/s41596-021-00589-z.
   PubMed Web of Science ®Google Scholar
• Poletti M, Arnauts K, Ferrante M, Korcsmaros T. Organoid-based models to study the role of host-microbiota interactions in IBD. J Crohns Colitis. 2021;15(7):1222–1235. doi:10.1093/ecco-jcc/jjaa257.
   PubMed Web of Science ®Google Scholar
• Ginga NJ, Slyman R, Kim G-A, Parigoris E, Huang S, Yadagiri VK, Young VB, Spence JR, Takayama S. Perfusion system for modification of luminal contents of human intestinal organoids and realtime imaging analysis of microbial populations. Micromachi (Basel). 2022;13(1):131. doi:10.3390/mi13010131.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Tuganbaev T, Skelly AN, Honda K. 2022. T Cell Responses to the Microbiota. Annu Rev Immunol. 40:559–587. doi:10.1146/annurev-immunol-101320-011829.
   PubMed Web of Science ®Google Scholar
• White J, Kappler J, Marrack P. Production and characterization of T cell hybridomas. Methods Mol Biol. 2000;134:185–193.
   PubMedGoogle Scholar
• Mann SE, Zhou Z, Landry LG, Anderson AM, Alkanani AK, Fischer J, Peakman M, Mallone R, Campbell K, Michels AW, et al. Multiplex T cell stimulation assay utilizing a T cell activation reporter-based detection system. Front Immunol. 2020;11:633. doi:10.3389/fimmu.2020.00633.
   PubMed Web of Science ®Google Scholar
• Chen R, Fulton KM, Twine SM, Li J. Identification of Mhc Peptides using Mass Spectrometry for neoantigen discovery and cancer vaccine Development. Mass Spectrom Rev. 2021;40(2):110–125. doi:10.1002/mas.21616.
   PubMed Web of Science ®Google Scholar
• Mayer RL, Impens F. Immunopeptidomics for next-generation bacterial vaccine development. Trends Microbiol. 2021;29(11):1034–1045. doi:10.1016/j.tim.2021.04.010.
   PubMed Web of Science ®Google Scholar
• Stopfer LE, Mesfin JM, Joughin BA, Lauffenburger DA, White FM. Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition. Nat Commun. 2020;11(1):2760. doi:10.1038/s41467-020-16588-9.
   PubMed Web of Science ®Google Scholar
• Wilkinson JE, Franzosa EA, Everett C, Li C, Bae S, Berzansky I, Bhosle A, Bjørnevik K, Brennan CA, Cao YG, et al. A framework for microbiome science in public health. Nat Med. 2021;27(5):766–774. doi:10.1038/s41591-021-01258-0.
   PubMed Web of Science ®Google Scholar
• Kassam Z, Dubois N, Ramakrishna B, Ling K, Qazi T, Smith M, Kelly CR, Fischer M, Allegretti JR, Budree S, et al. Donor screening for fecal microbiota transplantation. N Engl J Med. 2019;381(21):2070–2072. doi:10.1056/NEJMc1913670.
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen Q, Kelly CR, Kassam Z, Qin H, Li N, Tian H, Yang B, Zhao D, Ye C, et al. Donor screening for fecal microbiota transplantation in China: Evaluation of 8483 candidates. Gastroenterology. 2022;162(3):966–968 e3. doi:10.1053/j.gastro.2021.11.004.
   PubMed Web of Science ®Google Scholar
• Chen J, Zaman A, Ramakrishna B, Olesen SW. 2021. Stool banking for Fecal microbiota transplantation: Methods and operations at a large stool bank. Front Cell Infect Microbiol. 11:622949. doi:10.3389/fcimb.2021.622949.
   PubMed Web of Science ®Google Scholar
• 2022; Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-fecal-microbiota-product
   Google Scholar
• Carlson PE Jr. Regulatory considerations for fecal microbiota transplantation products. Cell Host Microbe. 2020;27(2):173–175. doi:10.1016/j.chom.2020.01.018.
   PubMed Web of Science ®Google Scholar
• Nearing JT, Comeau AM, Langille MGI. Identifying biases and their potential solutions in human microbiome studies. Microbiome. 2021;9(1):113. doi:10.1186/s40168-021-01059-0.
   PubMed Web of Science ®Google Scholar
• Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, Tramontano M, Driessen M, Hercog R, Jung F-E, et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol. 2017;35(11):1069–1076. doi:10.1038/nbt.3960.
   PubMed Web of Science ®Google Scholar
• Amos GCA, Sergaki C, Anwar, S. Fritzsche, M. Mate, R. Francis, Robert J. MacLellan-Gibson, K. Logan, A. Developing standards for the microbiome field. Microbiome. 2020;8(1):98. doi:10.1186/s40168-020-00856-3.
   PubMed Web of Science ®Google Scholar
• Sergaki C, Anwar, S. Fritzsche, M. Mate, R. Francis, Robert J. MacLellan-Gibson, K. Logan, A. Amos, Gregory CA. Developing whole cell standards for the microbiome field. Microbiome. 2022;10(1):123. doi:10.1186/s40168-022-01313-z.
   PubMed Web of Science ®Google Scholar
• Van Den Bossche T, Kunath BJ, Schallert K, Schäpe SS, Abraham PE, Armengaud J, Arntzen MØ, Bassignani A, Benndorf D, Fuchs S, et al. Critical Assessment of MetaProteome Investigation (CAMPI): a multi-laboratory comparison of established workflows. Nat Commun. 2021;12(1):7305. doi:10.1038/s41467-021-27542-8.
   PubMed Web of Science ®Google Scholar
• Tourlousse DM, K. Narita, T.Miura, M. Sakamoto, A. Ohashi, K. Shiina, M. Matsuda, D. Miura, M. Shimamura, Y. Ohyama. Validation and standardization of DNA extraction and library construction methods for metagenomics-based human fecal microbiome measurements. Microbiome. 2021;9(1):95. doi:10.1186/s40168-021-01048-3.
   PubMed Web of Science ®Google Scholar